期刊文献+

甲亢患者~(131)I治疗前后TRAb的变化分析 被引量:1

Analysis of Changes of TRAb of Hyperthyroidism Patients before and after the (131)I Treatment
在线阅读 下载PDF
导出
摘要 目的对甲亢患者^(131)I治疗前后的TRAb浓度变化进行分析,以观察其病症变化及预后效果。方法选取该院2015年1月—2016年1月初诊确诊后到其他医院接受(131)I治疗后到该院复诊的60例甲亢患者作为观察组,同时选取在该院进行健康体检的60名健康人员,对两组人员的血清TRAb浓度进行检测,以对观察组患者治疗前后TRAb浓度变化进行分析。结果与正常人员相比,观察组患者治疗前血清TRAb浓度为(83.47±42.14)U/L,差异有统计学意义(t=8.634,P<0.05);此外,随着时间增加,治疗后3、6、12个月观察组血清TRAb含量逐渐降低但与对照组对比,差异有统计学意义,分别为(52.78±41.23)U/L(t=6.327,P<0.05)、(22.54±21.37)U/L(t=5.182,P<0.05)、(18.76±10.25)U/L(t=4.836,P<0.05),其中,治疗后18个月观察组患者血清TRAb浓度为(3.42±5.14)U/L,与正常人员相比,差异无统计学意义(t=0.937,P>0.05)。结论 TRAb变化与甲亢患者的疾病发生以及病程、病症复发有着一定的相关性,是临床诊断及疗效评价的重要依据。 Objective To analyze the changes of TRAb of hyperthyroidism patients before and after the(131)I treatment and observe the disease changes and prognosis.Methods 60 cases of hyperthyroidism patients confirmed in the first visit in our hospital from January 2015 to January 2016 and for second visit in other hospitals after the(131)I treatment were selected as the observation group,and 60 cases of healthy staff for healthy physical examination in our hospital were selected,and the serum TRAb concentration of the two groups was tested,thus analyzing the changes of TRAb concentration changes before and after treatment in the observation groiup.Results The serum TRAb contration in the observation group before treatment was(83.47±42.14)U/L,and the difference between the normal staff and patients in the observation group was statistically significant(t=8.634,P<0.05),besides,with the increase of the time,the serum TRAb content in 3,6,12 months after treatment gradually decreased and the difference was obvious,respectively(52.78±41.23)U/L(t=6.327,P<0.05),(22.54±21.37)U/L(t=5.182,P<0.05),(18.76±10.25)U/L(t=4.836,P<0.05),and after treatment,the serum TRAb concentration in the observation group after 18 months was(3.42±5.14)U/L,and the difference was not statistically significant(t=0.937,P>0.05).Conclusion The changes of TRAb have a certain correlation with the occurrence of diseases and recurrence of diseases of patients with hyperthyroidism,which is a major basis for the clinical diagnosis and evaluation of curative effect.
作者 吴邦国 杨静升 高小宏 WU Bang-guo;YANG Jing-sheng;GAO Xiao-hong(Zhaotong First People’s Hospital,Zhaotong,Yunnan Province,657000 China)
出处 《系统医学》 2017年第24期29-31,共3页 Systems Medicine
关键词 甲亢 (131)I治疗 TRAb变化 Hyperthyroidism (131)I treatment TRAb changes
  • 相关文献

参考文献10

二级参考文献90

  • 1沈山梅,朱大龙,黄洪,韩光晓,黄群,冯雪峰.新诊断格雷夫斯病患者肝功能变化与甲状腺激素及抗体的关系[J].中国实用内科杂志,2005,25(8):733-734. 被引量:15
  • 2中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:861
  • 3崔邦平,蒋长斌,胡伟,杨建华,郭祖高.^(131)Ⅰ治疗Graves甲亢中动态监测血清TRAb的临床价值[J].中华核医学杂志,2007,27(5):295-296. 被引量:10
  • 4Chiovato L, Vitti P,Cucchi P,et al. The expression of the mi-crosomal/peroxidase autoantigen in human thyroid cells isthyrotrophin-dependent[J]. Clin Exp Immunol, 1989, 76 (1):47-53.
  • 5Nanba T, Watanabe M,Inoue N,et al. Increases of the Thl/Th2 cell ratio in severe Hashimoto1 s disease and in the pro-portion of Thl7 cells in intractable Graves,disease[J]. Thy-roid, 2009 ,19(5) :495-501.
  • 6Singer P A,Cooper D S,Levy E G,et al. Treatment guidelinesfor patients with hyperthyroidism and hypothyroidism [ J ].JAMA,1995,273(10) :808-812.
  • 7Zheng W, Jian T,Guizhi Z, et al. Analysis of i311 therapy andcorrelation factors of Graves- disease patients: a 4-year retro-spective study[J]. Nucl Med Commun,2012,33( 1) :97-101.
  • 8Walter M A,Christ-Crain M, Eckard B, et al. Radioiodinetherapy in hyperthyroidism : inverse correlation of prethera-peutic iodine uptake level and post-therapeutic outcome[J].Eur J Clin Invest,2004,34(5) :365-370.
  • 9Chiovato L,Fiore E, Vitti P,et al. Outcome of thyroid function inGrave幺 patients treated with radioiodine ? Role of thyroid-stimula-ting and thyrotropin-blocking antibodies and of radioiodine-inducedthyroid damage[J]. J Clin Endocrinol Metab,1998,83(1) : 40-46.
  • 10Rebuffat S A,Nguyen B,Robert B,et al. Antithyroperoxidaseantibody-dependent cytotoxicity in autoimmune thyroid dis-ease[J]. J Clin Endocrinol Metab,2008,93(3) : 929-934.

共引文献74

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部